Craig-Hallum lowered the firm’s price target on Ironwood (IRWD) to $7 from $8 and keeps a Buy rating on the shares. In the firm’s most recent ...
In the last three years, the government has virtually shut down the disinvestment and privatisation programme.
JMP Securities analyst Jason Butler lowered the firm’s price target on Ironwood (IRWD) to $14 from $23 and keeps an Outperform rating on the ...
JMP Securities adjusted their financial outlook on Ironwood Pharmaceuticals (NASDAQ:IRWD), setting a new price target of $14.00, a decrease from the previous target of $23.00. Despite the reduction, ...